Publications by authors named "Jose Loza"

Purpose: Multiple studies have reported that breast cancer in young patients is associated with aggressive characteristics, and it is suggested that prognosis is worse independently of pathologic variables.

Patients And Methods: We performed a retrospective analysis of the Breast Cancer Registry of the Argentinian Society of Mastology, including public and private centers. Patients ≤ 40 years of age at diagnosis were classified as "young," and patients ≤ 35 years of age at diagnosis were classified as "very young.

View Article and Find Full Text PDF

Background: Nodal staging constitutes an element of great importance in the treatment planning for early breast cancer. The ACOSOG Z0011 trial demonstrated that sentinel lymph node (SLN) biopsy alone results in rates of local control, disease-free survival, and overall survival equivalent to those seen after axillary lymph node dissection. The purpose of this study was to determine the rate of patients that fulfill the ACOSOG Z0011 inclusion criteria and to define predictive factors for non-SLN positivity.

View Article and Find Full Text PDF

Purpose: Several studies have shown that estrogen receptor (ER) and progesterone receptor (PR) expression and human epidermal growth factor receptor 2 (HER2) expression may vary during tumoral progression. We aimed to describe and compare ER, PR, and HER2 expressions in primary breast tumors and synchronic axillary nodal metastases, and evaluate phenotypic correlations between them.

Methods: Patients were identified prospectively through surgical procedures between September 2013 and July 2016.

View Article and Find Full Text PDF
Article Synopsis
  • - Clinical studies indicate that triple negative breast cancer (TNBC) patients with EGFR-expressing tumors may respond positively to Cetuximab, a drug that targets EGFR, but there’s a noted deficiency in how well NK cells can mediate the cancer-killing effects of this treatment.
  • - Researchers identified that high levels of the inhibitory receptor CD85j on NK cells were linked to a reduced ability to attack TNBC cells in the presence of Cetuximab, even when stimulating cytokines were present.
  • - Blocking CD85j function with a specific antibody improved NK cell activity against TNBC cells, suggesting that targeting immune activation issues could enhance the effectiveness of Cetuximab therapy in patients.
View Article and Find Full Text PDF

Triple-negative breast cancer (TNBC) patients do not benefit from target-specific treatments and is associated with a high relapse rate. Epidermal growth factor receptor is frequently expressed in TNBC and is a candidate for new therapies. In this work, we studied Cetuximab-mediated immune activity by NK cells.

View Article and Find Full Text PDF

Background: Glucose is the preferred carbon and energy source for Bacillus subtilis and Escherichia coli. A complex regulatory network coordinates gene expression, transport and enzymatic activities, in response to the presence of this sugar. We present a comparison of the cellular response to glucose in these two model organisms, using an approach combining global transcriptome and regulatory network analyses.

View Article and Find Full Text PDF

The transcriptional network of Escherichia coli may well be the most complete experimentally characterized network of a single cell. A rule-based approach was built to assess the degree of consistency between whole-genome microarray experiments in different experimental conditions and the accumulated knowledge in the literature compiled in RegulonDB, a data base of transcriptional regulation and operon organization in E. coli.

View Article and Find Full Text PDF